Status:
COMPLETED
Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function
Lead Sponsor:
Henry Ford Health System
Conditions:
Postoperative Graft Function
Eligibility:
All Genders
Brief Summary
Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure...
Detailed Description
During OLT, intraoperative TEE assessment of HVF (systolic and diastolic) were measured, and adjusted with donor graft weight. This index, HVF index, was assessed for correlation with EAD. HVF was cal...
Eligibility Criteria
Inclusion
- Orthotopic liver transplants which uses TEE intraoperatively Must be Piggy back technique
- \-
Exclusion
- TEE absolute contraindication patient refusal
Key Trial Info
Start Date :
February 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03814031
Start Date
February 20 2018
End Date
December 31 2019
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HFHS
Detroit, Michigan, United States, 48202